Drugmaker GlaxoSmithKline said Wednesday it will appeal an Illinois federal judge's decision denying the pharmaceutical company a new trial as it continues to fight a jury's award of $3 million to the widow of a Reed Smith LLP attorney who committed suicide while on a generic version of the company's antidepressant Paxil.
GlaxoSmithKline can’t have a new trial after losing a $3 million case over the suicide of a Reed Smith LLP attorney, an Illinois federal judge ruled Thursday, concluding among other things that an expert on stress at international law firms wouldn’t have changed the outcome.
GlaxoSmithKline pressed an Illinois federal court Monday to undo a $3 million verdict in favor of the widow of a Reed Smith LLP lawyer who committed suicide after taking generic Paxil, saying the prescribing doctor's knowledge of the risks relieved the drugmaker of responsibility.
The widow of a Reed Smith LLP attorney who died after taking a generic form of one of GlaxoSmithKline’s antidepressant drugs has blasted the company’s bid for a new trial, saying the company’s arguments for a do-over ignore evidence that does not fit its narrative.
GlaxoSmithKline asked an Illinois federal judge Thursday to grant it a new trial over a suit filed by the widow of a Reed Smith LLP attorney who died after taking a generic form of one of its antidepressants, arguing the jury’s finding that the company was liable for his suicide wasn’t supported by the evidence.
Thursday's $3 million jury verdict finding GlaxoSmithKline liable for a Reed Smith LLP partner's death means that the Seventh Circuit may finally have to answer a question it avoided three years ago, one that is a hot topic among product liability lawyers: Can brand-name manufacturers be held liable for an injury caused by a generic drug?
An Illinois federal jury on Thursday found GlaxoSmithKline liable for the death of Reed Smith LLP partner Stewart Dolin and ordered the pharmaceutical giant to pay $3 million to the attorney’s widow, reaching the conclusion that a generic version of GSK’s Paxil caused Dolin to take his own life.
The wife of a deceased Reed Smith partner said at the close of a five-week trial Monday that she’s owed $39 million for the loss of his income and companionship, blaming pharmaceutical giant GlaxoSmithKline and its well-known antidepressant Paxil for her husband’s suicide.
A former colleague of late Reed Smith LLP partner Stewart Dolin told an Illinois federal jury Tuesday that Dolin expressed trepidation shortly before his death about a client threatening to leave the firm, testimony that GlaxoSmithKline PLC hopes will convince the jury that it was not a generic Paxil prescription that caused Dolin to take his life.
A psychiatrist who helped prepare a GlaxoSmithKline PLC analysis of the suicide risk associated with Paxil told an Illinois federal jury Thursday that the drugmaker was not hiding anything from the U.S. Food and Drug Administration that could have prevented a Reed Smith attorney’s death.